CN108013453A - Children's lactose intolerance tailored version clinical nutrition formula and preparation method thereof - Google Patents
Children's lactose intolerance tailored version clinical nutrition formula and preparation method thereof Download PDFInfo
- Publication number
- CN108013453A CN108013453A CN201711332713.8A CN201711332713A CN108013453A CN 108013453 A CN108013453 A CN 108013453A CN 201711332713 A CN201711332713 A CN 201711332713A CN 108013453 A CN108013453 A CN 108013453A
- Authority
- CN
- China
- Prior art keywords
- parts
- children
- powder
- lactose intolerance
- clinical nutrition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 201000010538 Lactose Intolerance Diseases 0.000 title claims abstract description 45
- 235000016709 nutrition Nutrition 0.000 title claims abstract description 36
- 230000035764 nutrition Effects 0.000 title claims abstract description 33
- 238000009472 formulation Methods 0.000 title claims description 11
- 238000002360 preparation method Methods 0.000 title abstract description 8
- 239000011782 vitamin Substances 0.000 claims abstract description 27
- 229940088594 vitamin Drugs 0.000 claims abstract description 25
- 229930003231 vitamin Natural products 0.000 claims abstract description 25
- 235000013343 vitamin Nutrition 0.000 claims abstract description 25
- 235000012054 meals Nutrition 0.000 claims abstract description 21
- 102000004169 proteins and genes Human genes 0.000 claims abstract description 21
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 21
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 21
- 235000013305 food Nutrition 0.000 claims abstract description 14
- 239000011573 trace mineral Substances 0.000 claims abstract description 14
- 235000013619 trace mineral Nutrition 0.000 claims abstract description 14
- 230000035622 drinking Effects 0.000 claims abstract description 13
- 235000008216 herbs Nutrition 0.000 claims abstract description 13
- 230000010354 integration Effects 0.000 claims abstract description 13
- 150000001875 compounds Chemical class 0.000 claims abstract description 12
- 235000013325 dietary fiber Nutrition 0.000 claims abstract description 12
- 150000001720 carbohydrates Chemical class 0.000 claims abstract description 11
- 239000000843 powder Substances 0.000 claims description 90
- 235000018102 proteins Nutrition 0.000 claims description 20
- 235000019197 fats Nutrition 0.000 claims description 17
- 150000003722 vitamin derivatives Chemical class 0.000 claims description 16
- 235000015097 nutrients Nutrition 0.000 claims description 15
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 claims description 15
- 235000013312 flour Nutrition 0.000 claims description 13
- 241000196324 Embryophyta Species 0.000 claims description 11
- 235000010469 Glycine max Nutrition 0.000 claims description 11
- 238000000034 method Methods 0.000 claims description 11
- 235000014633 carbohydrates Nutrition 0.000 claims description 10
- 239000000203 mixture Substances 0.000 claims description 10
- 108090000765 processed proteins & peptides Proteins 0.000 claims description 10
- 230000001954 sterilising effect Effects 0.000 claims description 10
- 238000004659 sterilization and disinfection Methods 0.000 claims description 10
- 241000894006 Bacteria Species 0.000 claims description 9
- 229920002307 Dextran Polymers 0.000 claims description 9
- 108090000942 Lactalbumin Proteins 0.000 claims description 9
- 102000004407 Lactalbumin Human genes 0.000 claims description 9
- 102000014171 Milk Proteins Human genes 0.000 claims description 9
- 108010011756 Milk Proteins Proteins 0.000 claims description 9
- 240000004808 Saccharomyces cerevisiae Species 0.000 claims description 9
- 108010073771 Soybean Proteins Proteins 0.000 claims description 9
- 235000021239 milk protein Nutrition 0.000 claims description 9
- 239000006041 probiotic Substances 0.000 claims description 9
- 235000018291 probiotics Nutrition 0.000 claims description 9
- 235000019710 soybean protein Nutrition 0.000 claims description 9
- 235000000346 sugar Nutrition 0.000 claims description 9
- 241000522254 Cassia Species 0.000 claims description 8
- 102000008186 Collagen Human genes 0.000 claims description 8
- 108010035532 Collagen Proteins 0.000 claims description 8
- 229920002774 Maltodextrin Polymers 0.000 claims description 8
- 239000005913 Maltodextrin Substances 0.000 claims description 8
- GXCLVBGFBYZDAG-UHFFFAOYSA-N N-[2-(1H-indol-3-yl)ethyl]-N-methylprop-2-en-1-amine Chemical compound CN(CCC1=CNC2=C1C=CC=C2)CC=C GXCLVBGFBYZDAG-UHFFFAOYSA-N 0.000 claims description 8
- 244000197580 Poria cocos Species 0.000 claims description 8
- 235000008599 Poria cocos Nutrition 0.000 claims description 8
- 235000010575 Pueraria lobata Nutrition 0.000 claims description 8
- 244000046146 Pueraria lobata Species 0.000 claims description 8
- RQFQJYYMBWVMQG-IXDPLRRUSA-N chitotriose Chemical compound O[C@@H]1[C@@H](N)[C@H](O)O[C@H](CO)[C@H]1O[C@H]1[C@H](N)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)N)[C@@H](CO)O1 RQFQJYYMBWVMQG-IXDPLRRUSA-N 0.000 claims description 8
- 229920001436 collagen Polymers 0.000 claims description 8
- 230000007062 hydrolysis Effects 0.000 claims description 8
- 238000006460 hydrolysis reaction Methods 0.000 claims description 8
- 229940035034 maltodextrin Drugs 0.000 claims description 8
- 239000011435 rock Substances 0.000 claims description 8
- 229960003080 taurine Drugs 0.000 claims description 8
- 229920002752 Konjac Polymers 0.000 claims description 7
- 229920000377 Sinistrin Polymers 0.000 claims description 7
- 239000003094 microcapsule Substances 0.000 claims description 7
- -1 oligofructose Chemical compound 0.000 claims description 7
- 230000000529 probiotic effect Effects 0.000 claims description 7
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims description 6
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 6
- 239000007864 aqueous solution Substances 0.000 claims description 6
- 239000003292 glue Substances 0.000 claims description 6
- 244000068988 Glycine max Species 0.000 claims description 5
- 241001647745 Banksia Species 0.000 claims description 4
- 241000218176 Corydalis Species 0.000 claims description 4
- 241000220317 Rosa Species 0.000 claims description 4
- YZXBAPSDXZZRGB-DOFZRALJSA-N arachidonic acid Chemical compound CCCCC\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O YZXBAPSDXZZRGB-DOFZRALJSA-N 0.000 claims description 4
- BTCSSZJGUNDROE-UHFFFAOYSA-N gamma-aminobutyric acid Chemical compound NCCCC(O)=O BTCSSZJGUNDROE-UHFFFAOYSA-N 0.000 claims description 4
- 239000011259 mixed solution Substances 0.000 claims description 4
- 239000002245 particle Substances 0.000 claims description 4
- 229920001202 Inulin Polymers 0.000 claims description 3
- 150000001413 amino acids Chemical class 0.000 claims description 3
- 239000005018 casein Substances 0.000 claims description 3
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 claims description 3
- 235000021240 caseins Nutrition 0.000 claims description 3
- 239000003795 chemical substances by application Substances 0.000 claims description 3
- JYJIGFIDKWBXDU-MNNPPOADSA-N inulin Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)OC[C@]1(OC[C@]2(OC[C@]3(OC[C@]4(OC[C@]5(OC[C@]6(OC[C@]7(OC[C@]8(OC[C@]9(OC[C@]%10(OC[C@]%11(OC[C@]%12(OC[C@]%13(OC[C@]%14(OC[C@]%15(OC[C@]%16(OC[C@]%17(OC[C@]%18(OC[C@]%19(OC[C@]%20(OC[C@]%21(OC[C@]%22(OC[C@]%23(OC[C@]%24(OC[C@]%25(OC[C@]%26(OC[C@]%27(OC[C@]%28(OC[C@]%29(OC[C@]%30(OC[C@]%31(OC[C@]%32(OC[C@]%33(OC[C@]%34(OC[C@]%35(OC[C@]%36(O[C@@H]%37[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O%37)O)[C@H]([C@H](O)[C@@H](CO)O%36)O)[C@H]([C@H](O)[C@@H](CO)O%35)O)[C@H]([C@H](O)[C@@H](CO)O%34)O)[C@H]([C@H](O)[C@@H](CO)O%33)O)[C@H]([C@H](O)[C@@H](CO)O%32)O)[C@H]([C@H](O)[C@@H](CO)O%31)O)[C@H]([C@H](O)[C@@H](CO)O%30)O)[C@H]([C@H](O)[C@@H](CO)O%29)O)[C@H]([C@H](O)[C@@H](CO)O%28)O)[C@H]([C@H](O)[C@@H](CO)O%27)O)[C@H]([C@H](O)[C@@H](CO)O%26)O)[C@H]([C@H](O)[C@@H](CO)O%25)O)[C@H]([C@H](O)[C@@H](CO)O%24)O)[C@H]([C@H](O)[C@@H](CO)O%23)O)[C@H]([C@H](O)[C@@H](CO)O%22)O)[C@H]([C@H](O)[C@@H](CO)O%21)O)[C@H]([C@H](O)[C@@H](CO)O%20)O)[C@H]([C@H](O)[C@@H](CO)O%19)O)[C@H]([C@H](O)[C@@H](CO)O%18)O)[C@H]([C@H](O)[C@@H](CO)O%17)O)[C@H]([C@H](O)[C@@H](CO)O%16)O)[C@H]([C@H](O)[C@@H](CO)O%15)O)[C@H]([C@H](O)[C@@H](CO)O%14)O)[C@H]([C@H](O)[C@@H](CO)O%13)O)[C@H]([C@H](O)[C@@H](CO)O%12)O)[C@H]([C@H](O)[C@@H](CO)O%11)O)[C@H]([C@H](O)[C@@H](CO)O%10)O)[C@H]([C@H](O)[C@@H](CO)O9)O)[C@H]([C@H](O)[C@@H](CO)O8)O)[C@H]([C@H](O)[C@@H](CO)O7)O)[C@H]([C@H](O)[C@@H](CO)O6)O)[C@H]([C@H](O)[C@@H](CO)O5)O)[C@H]([C@H](O)[C@@H](CO)O4)O)[C@H]([C@H](O)[C@@H](CO)O3)O)[C@H]([C@H](O)[C@@H](CO)O2)O)[C@@H](O)[C@H](O)[C@@H](CO)O1 JYJIGFIDKWBXDU-MNNPPOADSA-N 0.000 claims description 3
- 229940029339 inulin Drugs 0.000 claims description 3
- 238000002156 mixing Methods 0.000 claims description 3
- 229910052757 nitrogen Inorganic materials 0.000 claims description 3
- 102000004196 processed proteins & peptides Human genes 0.000 claims description 3
- 238000012545 processing Methods 0.000 claims description 3
- OGNSCSPNOLGXSM-UHFFFAOYSA-N (+/-)-DABA Natural products NCCC(N)C(O)=O OGNSCSPNOLGXSM-UHFFFAOYSA-N 0.000 claims description 2
- MSWZFWKMSRAUBD-IVMDWMLBSA-N 2-amino-2-deoxy-D-glucopyranose Chemical compound N[C@H]1C(O)O[C@H](CO)[C@@H](O)[C@@H]1O MSWZFWKMSRAUBD-IVMDWMLBSA-N 0.000 claims description 2
- JDLKFOPOAOFWQN-VIFPVBQESA-N Allicin Natural products C=CCS[S@](=O)CC=C JDLKFOPOAOFWQN-VIFPVBQESA-N 0.000 claims description 2
- 229920000858 Cyclodextrin Polymers 0.000 claims description 2
- 229920001353 Dextrin Polymers 0.000 claims description 2
- 239000004375 Dextrin Substances 0.000 claims description 2
- 241000208688 Eucommia Species 0.000 claims description 2
- 229930091371 Fructose Natural products 0.000 claims description 2
- 239000005715 Fructose Substances 0.000 claims description 2
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 claims description 2
- 229920001503 Glucan Polymers 0.000 claims description 2
- UPYKUZBSLRQECL-UKMVMLAPSA-N Lycopene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1C(=C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=C)CCCC2(C)C UPYKUZBSLRQECL-UKMVMLAPSA-N 0.000 claims description 2
- JEVVKJMRZMXFBT-XWDZUXABSA-N Lycophyll Natural products OC/C(=C/CC/C(=C\C=C\C(=C/C=C/C(=C\C=C\C=C(/C=C/C=C(\C=C\C=C(/CC/C=C(/CO)\C)\C)/C)\C)/C)\C)/C)/C JEVVKJMRZMXFBT-XWDZUXABSA-N 0.000 claims description 2
- 240000003183 Manihot esculenta Species 0.000 claims description 2
- 235000016735 Manihot esculenta subsp esculenta Nutrition 0.000 claims description 2
- 229920000294 Resistant starch Polymers 0.000 claims description 2
- 240000002547 Rosa roxburghii Species 0.000 claims description 2
- 235000000640 Rosa roxburghii Nutrition 0.000 claims description 2
- UQZIYBXSHAGNOE-USOSMYMVSA-N Stachyose Natural products O(C[C@H]1[C@@H](O)[C@H](O)[C@H](O)[C@@H](O[C@@]2(CO)[C@H](O)[C@@H](O)[C@@H](CO)O2)O1)[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@H](CO[C@@H]2[C@@H](O)[C@@H](O)[C@@H](O)[C@H](CO)O2)O1 UQZIYBXSHAGNOE-USOSMYMVSA-N 0.000 claims description 2
- 235000010081 allicin Nutrition 0.000 claims description 2
- JDLKFOPOAOFWQN-UHFFFAOYSA-N allicin Chemical compound C=CCSS(=O)CC=C JDLKFOPOAOFWQN-UHFFFAOYSA-N 0.000 claims description 2
- 229940114079 arachidonic acid Drugs 0.000 claims description 2
- 235000021342 arachidonic acid Nutrition 0.000 claims description 2
- MSWZFWKMSRAUBD-UHFFFAOYSA-N beta-D-galactosamine Natural products NC1C(O)OC(CO)C(O)C1O MSWZFWKMSRAUBD-UHFFFAOYSA-N 0.000 claims description 2
- HEBKCHPVOIAQTA-NGQZWQHPSA-N d-xylitol Chemical compound OC[C@H](O)C(O)[C@H](O)CO HEBKCHPVOIAQTA-NGQZWQHPSA-N 0.000 claims description 2
- 235000019425 dextrin Nutrition 0.000 claims description 2
- 229930003944 flavone Natural products 0.000 claims description 2
- 150000002213 flavones Chemical class 0.000 claims description 2
- 235000011949 flavones Nutrition 0.000 claims description 2
- 229960003692 gamma aminobutyric acid Drugs 0.000 claims description 2
- 229960002442 glucosamine Drugs 0.000 claims description 2
- TWNIBLMWSKIRAT-VFUOTHLCSA-N levoglucosan Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@H]2CO[C@@H]1O2 TWNIBLMWSKIRAT-VFUOTHLCSA-N 0.000 claims description 2
- 239000007788 liquid Substances 0.000 claims description 2
- 235000012680 lutein Nutrition 0.000 claims description 2
- 229960005375 lutein Drugs 0.000 claims description 2
- 239000001656 lutein Substances 0.000 claims description 2
- KBPHJBAIARWVSC-RGZFRNHPSA-N lutein Chemical compound C([C@H](O)CC=1C)C(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\[C@H]1C(C)=C[C@H](O)CC1(C)C KBPHJBAIARWVSC-RGZFRNHPSA-N 0.000 claims description 2
- ORAKUVXRZWMARG-WZLJTJAWSA-N lutein Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=CC(O)CC2(C)C)C ORAKUVXRZWMARG-WZLJTJAWSA-N 0.000 claims description 2
- 235000012661 lycopene Nutrition 0.000 claims description 2
- 229960004999 lycopene Drugs 0.000 claims description 2
- 239000001751 lycopene Substances 0.000 claims description 2
- OAIJSZIZWZSQBC-GYZMGTAESA-N lycopene Chemical compound CC(C)=CCC\C(C)=C\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C=C(/C)CCC=C(C)C OAIJSZIZWZSQBC-GYZMGTAESA-N 0.000 claims description 2
- 238000004806 packaging method and process Methods 0.000 claims description 2
- 235000021254 resistant starch Nutrition 0.000 claims description 2
- HFHDHCJBZVLPGP-UHFFFAOYSA-N schardinger α-dextrin Chemical compound O1C(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(O)C2O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC2C(O)C(O)C1OC2CO HFHDHCJBZVLPGP-UHFFFAOYSA-N 0.000 claims description 2
- UQZIYBXSHAGNOE-XNSRJBNMSA-N stachyose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO[C@@H]2[C@@H]([C@@H](O)[C@@H](O)[C@@H](CO[C@@H]3[C@@H]([C@@H](O)[C@@H](O)[C@@H](CO)O3)O)O2)O)O1 UQZIYBXSHAGNOE-XNSRJBNMSA-N 0.000 claims description 2
- ZCIHMQAPACOQHT-ZGMPDRQDSA-N trans-isorenieratene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/c1c(C)ccc(C)c1C)C=CC=C(/C)C=Cc2c(C)ccc(C)c2C ZCIHMQAPACOQHT-ZGMPDRQDSA-N 0.000 claims description 2
- KBPHJBAIARWVSC-XQIHNALSSA-N trans-lutein Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2C(=CC(O)CC2(C)C)C KBPHJBAIARWVSC-XQIHNALSSA-N 0.000 claims description 2
- FJHBOVDFOQMZRV-XQIHNALSSA-N xanthophyll Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2C=C(C)C(O)CC2(C)C FJHBOVDFOQMZRV-XQIHNALSSA-N 0.000 claims description 2
- WQZGKKKJIJFFOK-QTVWNMPRSA-N D-mannopyranose Chemical compound OC[C@H]1OC(O)[C@@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-QTVWNMPRSA-N 0.000 claims 1
- 108010001441 Phosphopeptides Proteins 0.000 claims 1
- 241000489523 Veratrum Species 0.000 claims 1
- 206010012735 Diarrhoea Diseases 0.000 abstract description 17
- 208000024891 symptom Diseases 0.000 abstract description 17
- 230000036039 immunity Effects 0.000 abstract description 12
- 230000003185 calcium uptake Effects 0.000 abstract description 4
- 230000036541 health Effects 0.000 abstract description 4
- 230000003014 reinforcing effect Effects 0.000 abstract 1
- 230000006870 function Effects 0.000 description 17
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 16
- 239000008101 lactose Substances 0.000 description 16
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 12
- 239000011575 calcium Substances 0.000 description 12
- 229960005069 calcium Drugs 0.000 description 12
- 229910052791 calcium Inorganic materials 0.000 description 12
- 230000000968 intestinal effect Effects 0.000 description 12
- 238000010521 absorption reaction Methods 0.000 description 11
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 10
- 230000000694 effects Effects 0.000 description 10
- 230000012010 growth Effects 0.000 description 10
- 210000002784 stomach Anatomy 0.000 description 9
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 8
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 8
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 8
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 8
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 description 8
- 230000000052 comparative effect Effects 0.000 description 7
- 239000003814 drug Substances 0.000 description 7
- 239000000463 material Substances 0.000 description 7
- 206010000060 Abdominal distension Diseases 0.000 description 6
- 241000972773 Aulopiformes Species 0.000 description 6
- 235000013336 milk Nutrition 0.000 description 6
- 239000008267 milk Substances 0.000 description 6
- 210000004080 milk Anatomy 0.000 description 6
- 239000004006 olive oil Substances 0.000 description 6
- 235000008390 olive oil Nutrition 0.000 description 6
- 235000019515 salmon Nutrition 0.000 description 6
- 241001107116 Castanospermum australe Species 0.000 description 5
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 5
- 235000019483 Peanut oil Nutrition 0.000 description 5
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 5
- 235000009337 Spinacia oleracea Nutrition 0.000 description 5
- 244000300264 Spinacia oleracea Species 0.000 description 5
- 240000004922 Vigna radiata Species 0.000 description 5
- 235000010721 Vigna radiata var radiata Nutrition 0.000 description 5
- 235000011469 Vigna radiata var sublobata Nutrition 0.000 description 5
- 235000011453 Vigna umbellata Nutrition 0.000 description 5
- 240000001417 Vigna umbellata Species 0.000 description 5
- 235000019498 Walnut oil Nutrition 0.000 description 5
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 5
- 235000021279 black bean Nutrition 0.000 description 5
- 210000000988 bone and bone Anatomy 0.000 description 5
- 238000011161 development Methods 0.000 description 5
- 230000018109 developmental process Effects 0.000 description 5
- 229910052742 iron Inorganic materials 0.000 description 5
- 239000011777 magnesium Substances 0.000 description 5
- 229910052749 magnesium Inorganic materials 0.000 description 5
- 229940091250 magnesium supplement Drugs 0.000 description 5
- 239000000312 peanut oil Substances 0.000 description 5
- 239000011574 phosphorus Substances 0.000 description 5
- 229910052698 phosphorus Inorganic materials 0.000 description 5
- 239000008170 walnut oil Substances 0.000 description 5
- 229910052725 zinc Inorganic materials 0.000 description 5
- 239000011701 zinc Substances 0.000 description 5
- 235000011299 Brassica oleracea var botrytis Nutrition 0.000 description 4
- 235000017647 Brassica oleracea var italica Nutrition 0.000 description 4
- 240000003259 Brassica oleracea var. botrytis Species 0.000 description 4
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 4
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 4
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 description 4
- 229930003268 Vitamin C Natural products 0.000 description 4
- 229930003427 Vitamin E Natural products 0.000 description 4
- OENHQHLEOONYIE-UKMVMLAPSA-N all-trans beta-carotene Natural products CC=1CCCC(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C OENHQHLEOONYIE-UKMVMLAPSA-N 0.000 description 4
- 230000009286 beneficial effect Effects 0.000 description 4
- 235000013734 beta-carotene Nutrition 0.000 description 4
- 239000011648 beta-carotene Substances 0.000 description 4
- TUPZEYHYWIEDIH-WAIFQNFQSA-N beta-carotene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2=CCCCC2(C)C TUPZEYHYWIEDIH-WAIFQNFQSA-N 0.000 description 4
- 229960002747 betacarotene Drugs 0.000 description 4
- 229960002685 biotin Drugs 0.000 description 4
- 235000020958 biotin Nutrition 0.000 description 4
- 239000011616 biotin Substances 0.000 description 4
- 229960000304 folic acid Drugs 0.000 description 4
- 235000019152 folic acid Nutrition 0.000 description 4
- 239000011724 folic acid Substances 0.000 description 4
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 4
- 210000000936 intestine Anatomy 0.000 description 4
- 229960003512 nicotinic acid Drugs 0.000 description 4
- 235000001968 nicotinic acid Nutrition 0.000 description 4
- 239000011664 nicotinic acid Substances 0.000 description 4
- 239000003921 oil Substances 0.000 description 4
- 235000019198 oils Nutrition 0.000 description 4
- 239000011772 phylloquinone Substances 0.000 description 4
- 239000002994 raw material Substances 0.000 description 4
- 239000011734 sodium Substances 0.000 description 4
- 229910052708 sodium Inorganic materials 0.000 description 4
- 239000011726 vitamin B6 Substances 0.000 description 4
- 235000019154 vitamin C Nutrition 0.000 description 4
- 239000011718 vitamin C Substances 0.000 description 4
- 235000019165 vitamin E Nutrition 0.000 description 4
- 239000011709 vitamin E Substances 0.000 description 4
- 229940046009 vitamin E Drugs 0.000 description 4
- OENHQHLEOONYIE-JLTXGRSLSA-N β-Carotene Chemical compound CC=1CCCC(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C OENHQHLEOONYIE-JLTXGRSLSA-N 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- 241000251468 Actinopterygii Species 0.000 description 3
- 102100026189 Beta-galactosidase Human genes 0.000 description 3
- 108010059881 Lactase Proteins 0.000 description 3
- 235000010627 Phaseolus vulgaris Nutrition 0.000 description 3
- 244000046052 Phaseolus vulgaris Species 0.000 description 3
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 3
- 235000001014 amino acid Nutrition 0.000 description 3
- 229940024606 amino acid Drugs 0.000 description 3
- 108010005774 beta-Galactosidase Proteins 0.000 description 3
- 230000003750 conditioning effect Effects 0.000 description 3
- 230000013872 defecation Effects 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 208000035475 disorder Diseases 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 230000002708 enhancing effect Effects 0.000 description 3
- 235000019688 fish Nutrition 0.000 description 3
- 235000020256 human milk Nutrition 0.000 description 3
- 210000004251 human milk Anatomy 0.000 description 3
- 229940116108 lactase Drugs 0.000 description 3
- 210000002429 large intestine Anatomy 0.000 description 3
- 230000004060 metabolic process Effects 0.000 description 3
- 239000011591 potassium Substances 0.000 description 3
- 229910052700 potassium Inorganic materials 0.000 description 3
- NLKNQRATVPKPDG-UHFFFAOYSA-M potassium iodide Chemical compound [K+].[I-] NLKNQRATVPKPDG-UHFFFAOYSA-M 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- ZUFQODAHGAHPFQ-UHFFFAOYSA-N pyridoxine hydrochloride Chemical compound Cl.CC1=NC=C(CO)C(CO)=C1O ZUFQODAHGAHPFQ-UHFFFAOYSA-N 0.000 description 3
- 210000000952 spleen Anatomy 0.000 description 3
- 239000013589 supplement Substances 0.000 description 3
- GHOKWGTUZJEAQD-ZETCQYMHSA-N (D)-(+)-Pantothenic acid Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-ZETCQYMHSA-N 0.000 description 2
- WIGIZIANZCJQQY-UHFFFAOYSA-N 4-ethyl-3-methyl-N-[2-[4-[[[(4-methylcyclohexyl)amino]-oxomethyl]sulfamoyl]phenyl]ethyl]-5-oxo-2H-pyrrole-1-carboxamide Chemical compound O=C1C(CC)=C(C)CN1C(=O)NCCC1=CC=C(S(=O)(=O)NC(=O)NC2CCC(C)CC2)C=C1 WIGIZIANZCJQQY-UHFFFAOYSA-N 0.000 description 2
- 208000004998 Abdominal Pain Diseases 0.000 description 2
- FERIUCNNQQJTOY-UHFFFAOYSA-N Butyric acid Chemical compound CCCC(O)=O FERIUCNNQQJTOY-UHFFFAOYSA-N 0.000 description 2
- 229920001661 Chitosan Polymers 0.000 description 2
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- 102000015696 Interleukins Human genes 0.000 description 2
- 108010063738 Interleukins Proteins 0.000 description 2
- ABSPRNADVQNDOU-UHFFFAOYSA-N Menaquinone 1 Natural products C1=CC=C2C(=O)C(CC=C(C)C)=C(C)C(=O)C2=C1 ABSPRNADVQNDOU-UHFFFAOYSA-N 0.000 description 2
- 240000007594 Oryza sativa Species 0.000 description 2
- 235000007164 Oryza sativa Nutrition 0.000 description 2
- 235000002595 Solanum tuberosum Nutrition 0.000 description 2
- 244000061456 Solanum tuberosum Species 0.000 description 2
- 235000021307 Triticum Nutrition 0.000 description 2
- 244000098338 Triticum aestivum Species 0.000 description 2
- LXNHXLLTXMVWPM-UHFFFAOYSA-N Vitamin B6 Natural products CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 description 2
- 206010047700 Vomiting Diseases 0.000 description 2
- LPQOADBMXVRBNX-UHFFFAOYSA-N ac1ldcw0 Chemical compound Cl.C1CN(C)CCN1C1=C(F)C=C2C(=O)C(C(O)=O)=CN3CCSC1=C32 LPQOADBMXVRBNX-UHFFFAOYSA-N 0.000 description 2
- 235000010489 acacia gum Nutrition 0.000 description 2
- 239000001785 acacia senegal l. willd gum Substances 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 230000001580 bacterial effect Effects 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 235000013339 cereals Nutrition 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 230000001684 chronic effect Effects 0.000 description 2
- 210000001072 colon Anatomy 0.000 description 2
- 239000000470 constituent Substances 0.000 description 2
- 235000013365 dairy product Nutrition 0.000 description 2
- 235000005911 diet Nutrition 0.000 description 2
- 230000037213 diet Effects 0.000 description 2
- XBDQKXXYIPTUBI-UHFFFAOYSA-N dimethylselenoniopropionate Natural products CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 235000013399 edible fruits Nutrition 0.000 description 2
- 230000001804 emulsifying effect Effects 0.000 description 2
- 239000000839 emulsion Substances 0.000 description 2
- 229940088598 enzyme Drugs 0.000 description 2
- 238000000855 fermentation Methods 0.000 description 2
- 230000004151 fermentation Effects 0.000 description 2
- 239000000835 fiber Substances 0.000 description 2
- 239000007789 gas Substances 0.000 description 2
- 230000035876 healing Effects 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 210000002540 macrophage Anatomy 0.000 description 2
- 230000002503 metabolic effect Effects 0.000 description 2
- VNWKTOKETHGBQD-UHFFFAOYSA-N methane Chemical compound C VNWKTOKETHGBQD-UHFFFAOYSA-N 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 210000000822 natural killer cell Anatomy 0.000 description 2
- 235000015816 nutrient absorption Nutrition 0.000 description 2
- 229920001542 oligosaccharide Polymers 0.000 description 2
- 150000002482 oligosaccharides Chemical class 0.000 description 2
- 230000000242 pagocytic effect Effects 0.000 description 2
- SHUZOJHMOBOZST-UHFFFAOYSA-N phylloquinone Natural products CC(C)CCCCC(C)CCC(C)CCCC(=CCC1=C(C)C(=O)c2ccccc2C1=O)C SHUZOJHMOBOZST-UHFFFAOYSA-N 0.000 description 2
- MBWXNTAXLNYFJB-NKFFZRIASA-N phylloquinone Chemical compound C1=CC=C2C(=O)C(C/C=C(C)/CCC[C@H](C)CCC[C@H](C)CCCC(C)C)=C(C)C(=O)C2=C1 MBWXNTAXLNYFJB-NKFFZRIASA-N 0.000 description 2
- 235000019175 phylloquinone Nutrition 0.000 description 2
- 229960001898 phytomenadione Drugs 0.000 description 2
- 235000013594 poultry meat Nutrition 0.000 description 2
- RADKZDMFGJYCBB-UHFFFAOYSA-N pyridoxal hydrochloride Natural products CC1=NC=C(CO)C(C=O)=C1O RADKZDMFGJYCBB-UHFFFAOYSA-N 0.000 description 2
- 235000009566 rice Nutrition 0.000 description 2
- 238000005507 spraying Methods 0.000 description 2
- 238000005728 strengthening Methods 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 239000011716 vitamin B2 Substances 0.000 description 2
- 235000019158 vitamin B6 Nutrition 0.000 description 2
- 239000011647 vitamin D3 Substances 0.000 description 2
- 229940011671 vitamin b6 Drugs 0.000 description 2
- 230000008673 vomiting Effects 0.000 description 2
- LDVVTQMJQSCDMK-UHFFFAOYSA-N 1,3-dihydroxypropan-2-yl formate Chemical compound OCC(CO)OC=O LDVVTQMJQSCDMK-UHFFFAOYSA-N 0.000 description 1
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- ODHCTXKNWHHXJC-VKHMYHEASA-N 5-oxo-L-proline Chemical compound OC(=O)[C@@H]1CCC(=O)N1 ODHCTXKNWHHXJC-VKHMYHEASA-N 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- 235000001674 Agaricus brunnescens Nutrition 0.000 description 1
- 241000143060 Americamysis bahia Species 0.000 description 1
- 241000512259 Ascophyllum nodosum Species 0.000 description 1
- 241000186000 Bifidobacterium Species 0.000 description 1
- 241000167854 Bourreria succulenta Species 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- GHOKWGTUZJEAQD-UHFFFAOYSA-N Chick antidermatitis factor Natural products OCC(C)(C)C(O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-UHFFFAOYSA-N 0.000 description 1
- 241000206575 Chondrus crispus Species 0.000 description 1
- 241000207199 Citrus Species 0.000 description 1
- 235000007354 Coix lacryma jobi Nutrition 0.000 description 1
- 244000077995 Coix lacryma jobi Species 0.000 description 1
- 206010010356 Congenital anomaly Diseases 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- 208000034657 Convalescence Diseases 0.000 description 1
- OCUCCJIRFHNWBP-IYEMJOQQSA-L Copper gluconate Chemical compound [Cu+2].OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O OCUCCJIRFHNWBP-IYEMJOQQSA-L 0.000 description 1
- 244000241257 Cucumis melo Species 0.000 description 1
- 235000015510 Cucumis melo subsp melo Nutrition 0.000 description 1
- 241000371652 Curvularia clavata Species 0.000 description 1
- 244000000626 Daucus carota Species 0.000 description 1
- 235000002767 Daucus carota Nutrition 0.000 description 1
- 241000238557 Decapoda Species 0.000 description 1
- RWSOTUBLDIXVET-UHFFFAOYSA-N Dihydrogen sulfide Chemical compound S RWSOTUBLDIXVET-UHFFFAOYSA-N 0.000 description 1
- 240000001008 Dimocarpus longan Species 0.000 description 1
- 240000005717 Dioscorea alata Species 0.000 description 1
- 235000000235 Euphoria longan Nutrition 0.000 description 1
- 235000009419 Fagopyrum esculentum Nutrition 0.000 description 1
- 240000008620 Fagopyrum esculentum Species 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 241000287828 Gallus gallus Species 0.000 description 1
- 206010067715 Gastrointestinal sounds abnormal Diseases 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 102000001554 Hemoglobins Human genes 0.000 description 1
- 108010054147 Hemoglobins Proteins 0.000 description 1
- SQUHHTBVTRBESD-UHFFFAOYSA-N Hexa-Ac-myo-Inositol Natural products CC(=O)OC1C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C1OC(C)=O SQUHHTBVTRBESD-UHFFFAOYSA-N 0.000 description 1
- 208000031361 Hiccup Diseases 0.000 description 1
- ODKSFYDXXFIFQN-BYPYZUCNSA-N L-arginine Chemical compound OC(=O)[C@@H](N)CCCN=C(N)N ODKSFYDXXFIFQN-BYPYZUCNSA-N 0.000 description 1
- 229930064664 L-arginine Natural products 0.000 description 1
- 235000014852 L-arginine Nutrition 0.000 description 1
- ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 description 1
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 description 1
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 1
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 1
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 description 1
- 241000408747 Lepomis gibbosus Species 0.000 description 1
- 102000004895 Lipoproteins Human genes 0.000 description 1
- 108090001030 Lipoproteins Proteins 0.000 description 1
- 235000007688 Lycopersicon esculentum Nutrition 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 241000736262 Microbiota Species 0.000 description 1
- 235000009811 Momordica charantia Nutrition 0.000 description 1
- 235000009812 Momordica cochinchinensis Nutrition 0.000 description 1
- 240000001740 Momordica dioica Species 0.000 description 1
- 235000018365 Momordica dioica Nutrition 0.000 description 1
- NIPNSKYNPDTRPC-UHFFFAOYSA-N N-[2-oxo-2-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)ethyl]-2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidine-5-carboxamide Chemical compound O=C(CNC(=O)C=1C=NC(=NC=1)NCC1=CC(=CC=C1)OC(F)(F)F)N1CC2=C(CC1)NN=N2 NIPNSKYNPDTRPC-UHFFFAOYSA-N 0.000 description 1
- 240000002853 Nelumbo nucifera Species 0.000 description 1
- 235000006508 Nelumbo nucifera Nutrition 0.000 description 1
- 235000006510 Nelumbo pentapetala Nutrition 0.000 description 1
- 102000015636 Oligopeptides Human genes 0.000 description 1
- 108010038807 Oligopeptides Proteins 0.000 description 1
- 235000019482 Palm oil Nutrition 0.000 description 1
- 235000004347 Perilla Nutrition 0.000 description 1
- 244000124853 Perilla frutescens Species 0.000 description 1
- 241001300674 Plukenetia volubilis Species 0.000 description 1
- 241000382353 Pupa Species 0.000 description 1
- 241000287420 Pyrus x nivalis Species 0.000 description 1
- 244000088415 Raphanus sativus Species 0.000 description 1
- 235000006140 Raphanus sativus var sativus Nutrition 0.000 description 1
- QNVSXXGDAPORNA-UHFFFAOYSA-N Resveratrol Natural products OC1=CC=CC(C=CC=2C=C(O)C(O)=CC=2)=C1 QNVSXXGDAPORNA-UHFFFAOYSA-N 0.000 description 1
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 1
- 240000003768 Solanum lycopersicum Species 0.000 description 1
- 244000062793 Sorghum vulgare Species 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 235000019486 Sunflower oil Nutrition 0.000 description 1
- LUKBXSAWLPMMSZ-OWOJBTEDSA-N Trans-resveratrol Chemical compound C1=CC(O)=CC=C1\C=C\C1=CC(O)=CC(O)=C1 LUKBXSAWLPMMSZ-OWOJBTEDSA-N 0.000 description 1
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- 229930003316 Vitamin D Natural products 0.000 description 1
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 description 1
- 239000005862 Whey Substances 0.000 description 1
- 102000007544 Whey Proteins Human genes 0.000 description 1
- 108010046377 Whey Proteins Proteins 0.000 description 1
- 240000008042 Zea mays Species 0.000 description 1
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 1
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 1
- WHMDKBIGKVEYHS-IYEMJOQQSA-L Zinc gluconate Chemical compound [Zn+2].OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O WHMDKBIGKVEYHS-IYEMJOQQSA-L 0.000 description 1
- FJJCIZWZNKZHII-UHFFFAOYSA-N [4,6-bis(cyanoamino)-1,3,5-triazin-2-yl]cyanamide Chemical compound N#CNC1=NC(NC#N)=NC(NC#N)=N1 FJJCIZWZNKZHII-UHFFFAOYSA-N 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 201000009840 acute diarrhea Diseases 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 208000007502 anemia Diseases 0.000 description 1
- 235000021120 animal protein Nutrition 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- 239000003212 astringent agent Substances 0.000 description 1
- 235000015278 beef Nutrition 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 230000036765 blood level Effects 0.000 description 1
- 235000008429 bread Nutrition 0.000 description 1
- 235000014121 butter Nutrition 0.000 description 1
- FNAQSUUGMSOBHW-UHFFFAOYSA-H calcium citrate Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O.[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O FNAQSUUGMSOBHW-UHFFFAOYSA-H 0.000 description 1
- 239000001354 calcium citrate Substances 0.000 description 1
- FUFJGUQYACFECW-UHFFFAOYSA-L calcium hydrogenphosphate Chemical compound [Ca+2].OP([O-])([O-])=O FUFJGUQYACFECW-UHFFFAOYSA-L 0.000 description 1
- MKJXYGKVIBWPFZ-CEOVSRFSSA-L calcium;(2s)-2-hydroxypropanoate Chemical compound [Ca+2].C[C@H](O)C([O-])=O.C[C@H](O)C([O-])=O MKJXYGKVIBWPFZ-CEOVSRFSSA-L 0.000 description 1
- MWKXCSMICWVRGW-UHFFFAOYSA-N calcium;phosphane Chemical compound P.[Ca] MWKXCSMICWVRGW-UHFFFAOYSA-N 0.000 description 1
- 239000010495 camellia oil Substances 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 238000002144 chemical decomposition reaction Methods 0.000 description 1
- 235000019693 cherries Nutrition 0.000 description 1
- 230000008131 children development Effects 0.000 description 1
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 description 1
- 229960001231 choline Drugs 0.000 description 1
- 235000020971 citrus fruits Nutrition 0.000 description 1
- FDJOLVPMNUYSCM-WZHZPDAFSA-L cobalt(3+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(1r,2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2 Chemical compound [Co+3].N#[C-].N([C@@H]([C@]1(C)[N-]\C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C(\C)/C1=N/C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C\C1=N\C([C@H](C1(C)C)CCC(N)=O)=C/1C)[C@@H]2CC(N)=O)=C\1[C@]2(C)CCC(=O)NC[C@@H](C)OP([O-])(=O)O[C@H]1[C@@H](O)[C@@H](N2C3=CC(C)=C(C)C=C3N=C2)O[C@@H]1CO FDJOLVPMNUYSCM-WZHZPDAFSA-L 0.000 description 1
- 239000003240 coconut oil Substances 0.000 description 1
- 235000019864 coconut oil Nutrition 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 229940108925 copper gluconate Drugs 0.000 description 1
- 235000005822 corn Nutrition 0.000 description 1
- 235000005687 corn oil Nutrition 0.000 description 1
- 239000002285 corn oil Substances 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 230000000593 degrading effect Effects 0.000 description 1
- 230000037123 dental health Effects 0.000 description 1
- 235000019700 dicalcium phosphate Nutrition 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 230000001079 digestive effect Effects 0.000 description 1
- 150000002016 disaccharides Chemical class 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 235000019441 ethanol Nutrition 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 239000003925 fat Substances 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 239000004222 ferrous gluconate Substances 0.000 description 1
- 235000013924 ferrous gluconate Nutrition 0.000 description 1
- 229960001645 ferrous gluconate Drugs 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 235000021323 fish oil Nutrition 0.000 description 1
- 206010016766 flatulence Diseases 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- 239000004519 grease Substances 0.000 description 1
- 230000002439 hemostatic effect Effects 0.000 description 1
- 238000000265 homogenisation Methods 0.000 description 1
- 238000007654 immersion Methods 0.000 description 1
- 230000001900 immune effect Effects 0.000 description 1
- 230000007365 immunoregulation Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 238000001802 infusion Methods 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- CDAISMWEOUEBRE-GPIVLXJGSA-N inositol Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@@H]1O CDAISMWEOUEBRE-GPIVLXJGSA-N 0.000 description 1
- 229960000367 inositol Drugs 0.000 description 1
- ATEAWHILRRXHPW-UHFFFAOYSA-J iron(2+);phosphonato phosphate Chemical compound [Fe+2].[Fe+2].[O-]P([O-])(=O)OP([O-])([O-])=O ATEAWHILRRXHPW-UHFFFAOYSA-J 0.000 description 1
- VRIVJOXICYMTAG-IYEMJOQQSA-L iron(ii) gluconate Chemical group [Fe+2].OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O VRIVJOXICYMTAG-IYEMJOQQSA-L 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 235000020190 lactose-free milk Nutrition 0.000 description 1
- 239000000787 lecithin Substances 0.000 description 1
- 235000010445 lecithin Nutrition 0.000 description 1
- 229940067606 lecithin Drugs 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 230000033001 locomotion Effects 0.000 description 1
- 235000004213 low-fat Nutrition 0.000 description 1
- 239000001755 magnesium gluconate Substances 0.000 description 1
- 229960003035 magnesium gluconate Drugs 0.000 description 1
- 235000015778 magnesium gluconate Nutrition 0.000 description 1
- IAKLPCRFBAZVRW-XRDLMGPZSA-L magnesium;(2r,3s,4r,5r)-2,3,4,5,6-pentahydroxyhexanoate;hydrate Chemical compound O.[Mg+2].OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O IAKLPCRFBAZVRW-XRDLMGPZSA-L 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 235000019713 millet Nutrition 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 239000003595 mist Substances 0.000 description 1
- 235000021281 monounsaturated fatty acids Nutrition 0.000 description 1
- 235000014571 nuts Nutrition 0.000 description 1
- 230000003204 osmotic effect Effects 0.000 description 1
- GSSMIHQEWAQUPM-AOLPDKKJSA-N ovalbumin peptide Chemical compound C([C@H](NC(=O)[C@H](C(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)[C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1NC=NC=1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CCCNC(N)=N)C(O)=O)C1=CN=CN1 GSSMIHQEWAQUPM-AOLPDKKJSA-N 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 239000002540 palm oil Substances 0.000 description 1
- 229940055726 pantothenic acid Drugs 0.000 description 1
- 235000019161 pantothenic acid Nutrition 0.000 description 1
- 239000011713 pantothenic acid Substances 0.000 description 1
- 239000001335 perilla frutescens leaf extract Substances 0.000 description 1
- 230000008855 peristalsis Effects 0.000 description 1
- 230000002085 persistent effect Effects 0.000 description 1
- 230000035479 physiological effects, processes and functions Effects 0.000 description 1
- 238000006116 polymerization reaction Methods 0.000 description 1
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 description 1
- 229920000053 polysorbate 80 Polymers 0.000 description 1
- 235000020777 polyunsaturated fatty acids Nutrition 0.000 description 1
- 235000015277 pork Nutrition 0.000 description 1
- 235000007715 potassium iodide Nutrition 0.000 description 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
- 235000019260 propionic acid Nutrition 0.000 description 1
- 235000020236 pumpkin seed Nutrition 0.000 description 1
- IUVKMZGDUIUOCP-BTNSXGMBSA-N quinbolone Chemical compound O([C@H]1CC[C@H]2[C@H]3[C@@H]([C@]4(C=CC(=O)C=C4CC3)C)CC[C@@]21C)C1=CCCC1 IUVKMZGDUIUOCP-BTNSXGMBSA-N 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 235000021283 resveratrol Nutrition 0.000 description 1
- 229940016667 resveratrol Drugs 0.000 description 1
- 239000003813 safflower oil Substances 0.000 description 1
- 150000004671 saturated fatty acids Chemical group 0.000 description 1
- 230000002000 scavenging effect Effects 0.000 description 1
- CDAISMWEOUEBRE-UHFFFAOYSA-N scyllo-inosotol Natural products OC1C(O)C(O)C(O)C(O)C1O CDAISMWEOUEBRE-UHFFFAOYSA-N 0.000 description 1
- MCAHWIHFGHIESP-UHFFFAOYSA-N selenous acid Chemical compound O[Se](O)=O MCAHWIHFGHIESP-UHFFFAOYSA-N 0.000 description 1
- 239000001509 sodium citrate Substances 0.000 description 1
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 239000003549 soybean oil Substances 0.000 description 1
- 235000012424 soybean oil Nutrition 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 150000003431 steroids Chemical class 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 239000002600 sunflower oil Substances 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 235000013337 tricalcium citrate Nutrition 0.000 description 1
- 239000004474 valine Substances 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 235000019156 vitamin B Nutrition 0.000 description 1
- 239000011720 vitamin B Substances 0.000 description 1
- 239000011691 vitamin B1 Substances 0.000 description 1
- 239000011715 vitamin B12 Substances 0.000 description 1
- 235000019166 vitamin D Nutrition 0.000 description 1
- 239000011710 vitamin D Substances 0.000 description 1
- 150000003710 vitamin D derivatives Chemical class 0.000 description 1
- QYSXJUFSXHHAJI-YRZJJWOYSA-N vitamin D3 Chemical compound C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C\C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-YRZJJWOYSA-N 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
- 229940046001 vitamin b complex Drugs 0.000 description 1
- 229940046008 vitamin d Drugs 0.000 description 1
- 239000011670 zinc gluconate Substances 0.000 description 1
- 235000011478 zinc gluconate Nutrition 0.000 description 1
- 229960000306 zinc gluconate Drugs 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/125—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives containing carbohydrate syrups; containing sugars; containing sugar alcohols; containing starch hydrolysates
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/15—Vitamins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/15—Vitamins
- A23L33/155—Vitamins A or D
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/16—Inorganic salts, minerals or trace elements
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/175—Amino acids
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/185—Vegetable proteins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/19—Dairy proteins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Food Science & Technology (AREA)
- Nutrition Science (AREA)
- Engineering & Computer Science (AREA)
- Mycology (AREA)
- Polymers & Plastics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Inorganic Chemistry (AREA)
- Pediatric Medicine (AREA)
- Molecular Biology (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
The present invention provides a kind of children's lactose intolerance tailored version clinical nutrition formula, including following component and its parts by weight:15 22 parts of protein, 6 10 parts of fat, 43 58 parts of carbohydrate, 7 10 parts of dietary fibers, 0.01 0.15 parts of macroelements, 0.001 0.004 parts of trace elements, 0.001 0.003 parts of liposoluble vitamins, 0.01 0.03 parts of water soluble vitamins, 0.005 0.02 parts of meals elite, 0.0005 0.5 parts of integration of drinking and medicinal herbs components, 0.05 0.4 parts of natural plants compounds and 0.01 0.02 parts of new resource foods;The present invention also provides the preparation method for being related to two kinds of above-mentioned clinical nutrition formulas.The present invention alleviates the symptom of diarrhea of children lactose-intolerant person to provide comprehensive nutritional support, reinforcing calcium uptake with lactose intolerance children, nurses one's health enteron aisle, promotes enteron aisle to digest and assimilate, strengthens children's immunity of organisms.
Description
Technical field
The present invention relates to special medicine purposes formula food field, more particularly to a kind of children's lactose intolerance tailored version to face
Bed nutrient formulation and preparation method thereof.
Background technology
Lactose is a kind of disaccharide, its molecule is made of glucose and galactolipin, and lactose cannot directly be inhaled in human body
Receipts could be absorbed, it is necessary to be decomposed under the action of lactase, is lacked the crowd of galantase after lactose is taken in, is not disappeared
The lactose of change is directly entered large intestine, stimulates intestinal peristalsis to accelerate, causes the symptoms such as borborygmus, diarrhea to claim lactose intolerance.
Lactose intolerance crowd is after lactose is taken in, and since body lacks lactase in itself, the lactose of intake cannot
It is digested and is absorbed into blood, but is trapped in enteron aisle.Enteric bacterial fermentation can produce a large amount of gases during reducing lactose.Make
Into abdominal distension, passwind.Excessive lactose can also raise the osmotic pressure inside enteron aisle, prevent to cause diarrhea to the absorption of moisture;When
The lactose of undecomposed absorption enter colon after, existing for enteron aisle bacterial fermentation become small molecule organic acid for example acetic acid, propionic acid,
Butyric acid etc., and produce some gases such as methane, H2、CO2Deng.
The incidence of children's lactose intolerance is about 48%-58%.Most of baby with lactose intolerance symptom
It is because the congenital shortage lactase of enteron aisle, causes lactose to be hydrolyzed in small enteral and be directly entered large intestine, in colon bacteria
Under the action of produce sour gas, stimulate enteron aisle thus cause abdominal pain, abdominal distension and diarrhea, since children's large intestine Scavenging activity is compared with year
Long youngster and adult are poor, so diarrhea becomes apparent from, either eating the baby of breast milk or milk can occur.Children's lactose intolerance
Cardinal symptom shows as flatulence (for example have the hiccups, the tripe that rises, spit milk) and diarrhea.
Infant be child growth development critical period, it is necessary to general equilibrium supplement the nutrients, otherwise can cause physique
A series of problems, such as developing slow, figure weakness, constipation, slow-witted reaction.If for example, remove treasured because of lactose intolerance symptom
Dairy products in precious diet, can cause the calcium source deficiency needed for baby, influence bone and the dental health growth of baby;Lactose is not
Symptom of diarrhea caused by tolerance, can cause baby's increased defecation, influence the stomach absorption function of baby.
Low lactose milk or lactose-free milk powder, soya-bean milk, rice product clinically are eaten for children's lactose intolerance at present,
But relative to breast milk feeding, non-breast milk feeding lacks the energy matter, the strong material of antibacterial, life of baby's life growth development needs
Auto-regulator, vitamin and trace element are managed, so as to influence the growth and development of baby, reduces the immunocompetence of baby.
Research shows that Chinese cassia tree, pueraria lobata, Rhizoma Atractylodis Macrocephalae, Poria cocos, malt, radix glycyrrhizae, corydalis tuber, rhizoma zingiberis, windproof, the banksia rose etc., which have, to be mended
The effect of middle QI invigorating, strengthening the spleen and stomach, relieving diarrhea with astringents, analgesic hemostatic, muscle-growing and detumescence, can alleviate the symptoms such as abdominal pain, abdominal distension, diarrhea,
Help to recover stomach absorption function.Such medicine diarrhea for caused by function of intestinal canal disorder has good recovery effects.
The content of the invention
The defects of it is an object of the invention to overcome in the prior art, there is provided a kind of children's lactose intolerance tailored version is clinical
Nutrient formulation and preparation method thereof, it is according to the clinical nutrition feature of children's lactose intolerance, rightly to protein, carbon aquation
Compound and fat mass ratio are adjusted, and are stopped feeding higher fatty acid and are difficult to the food digested, to mitigate stomach and intestine burden, by
Gradually recover digestive function;Milk protein and lactose are not added, while is properly added lactalbumin and probiotics.Ensure children growth
Nutrient necessary to development, strengthens calcium uptake, and can successfully manage the symptoms such as diarrhea caused by lactose intolerance, nurses one's health intestines
Road, recovers the stomach absorption function of children as early as possible, improves the absorbability to nutrition, strengthens immunity of organisms, makes children extensive
The multiple phase puts on weight and improves human body nutrition condition comprehensively as early as possible.
To achieve the above object, the present invention adopts the following technical scheme that:
First purpose of the present invention is to provide a kind of children's lactose intolerance tailored version clinical nutrition formula, including as follows
Component and its parts by weight:15-22 parts of protein, 6-10 parts of fat, 43-58 parts of carbohydrate, 7-10 parts of dietary fibers,
0.7-1.1 parts of macroelements, 0.004-0.01 parts of trace elements, 0.001-0.003 parts of liposoluble vitamins, 0.01-0.03 parts
Water soluble vitamin, 0.005-0.1 parts of meals elite, 0.0005-0.5 parts of integration of drinking and medicinal herbs components, 0.05-0.4 parts of natural plants
Compound and 0.01-0.02 parts of new resource foods.
In order to further optimize above-mentioned clinical nutrition formula, the technical measures that the present invention is taken further include:
Preferably, the protein for lactalbumin, hydrolyzed milk protein, soybean protein isolate, hydrolysis Isin glue collagen,
At least one of amino acid, protein peptides.
Wherein, the amino acid is selected from L-lysine-Pidolidone, Pidolidone, L-arginine, L-Trp, L- paddy
At least one of glutamine, taurine, Valine, l-Isoleucine, L-Leu;The protein peptides are selected from soy oligosaccharides
In peptide, wheat protein peptide, pupa albumen peptide, ocean fish oligopeptide powder, laughable peptide, amino peptide, casein calcium peptide, ovalbumin peptide
At least one.
It is highly preferred that the protein includes lactalbumin, hydrolyzed milk protein, soybean protein isolate, hydrolysis collagen
Albumen, taurine.
Preferably, the fat is saturated fatty acid, polyunsaturated fatty acid, monounsaturated fatty acids, OPO structures
At least one of fat, DHA, EPA, ARA, phosphatide, more specifically described fat include safflower seed oil, walnut oil, peanut oil,
Soybean oil, corn oil, Ah's glycerine, olive oil, tea oil, oil and fat of sacha inchi, olive oil, coconut oil, sunflower oil, perilla herb oil, deep-sea fish
Oil, cupu oil, palm oil, butter, cream, lard, lecithin, Purple Perilla Seed Oil etc.;More preferably walnut oil, olive oil, peanut
Oil.
Preferably, the carbohydrate is included in fructose, rock sugar, maltodextrin, rock sugar, tapioca, resistant starch
At least two;More preferably maltodextrin and rock sugar.
Preferably, the dietary fiber be inulin, it is konjaku flour, polyfructosan, soybean polyoses, cyclodextrin, resistant dextrin, big
At least one of beans fiber;More preferably konjaku flour and polyfructosan.
Preferably, the macroelement for calcium citrate, L-calcium lactate, calcium monohydrogen phosphate, K-IAO, sodium citrate and
At least one of magnesium gluconate.
Preferably, the trace element is ferrous gluconate, ferrous pyrophosphate, potassium iodide, zinc gluconate, selenous acid
At least one of sodium, copper gluconate.
Preferably, the liposoluble vitamin is vitamin A, beta carotene, vitamin D3, vitamin E, vitamin K1In
At least one.
Preferably, the water soluble vitamin is vitamin B1, vitamin B2, vitamin B6, vitamin B12, vitamin C,
At least one of pantothenic acid, folic acid, nicotinic acid, choline, inositol, biotin.
Preferably, the meals elite is selected from cereal, beans, potato, greengrocery, Homonemeae, nut-seed class, fishes and shrimps
At least one of class, poultry meat, fruits;The cereal is selected from rice meal, millet powder, black rice flour, coixlacrymajobi powder, corn
At least one of powder, wheat germ powder, oatmeal, buckwheat;The beans is selected from peameal, mung bean flour, black bean powder, red bean
At least one of powder, soy meal;The potato is mainly made of common yam rhizome powder;The Vegetable powder is selected from carrot meal, white radish powder, south
At least one of melon powder, spinach powder, tomato meal, broccoli powder, balsam pear powder;The Homonemeae be selected from mushroom powder, Kelp Powder and
At least one of white fungus powder;The nut-seed class is selected from least one of pumpkin seed powder and lotus nut starch;The fish and shrimp
Selected from least one of salmon powder, salmon powder, cod meal;The poultry meat is selected from chicken meal, powdered beef, pork liver powder
At least one of with pig kidney powder;The fruits be selected from red date powder, longan powder, apple powder, cherry powder, citrus powder, pyrus nivalis powder,
At least one of orange powder.
Preferably, the integration of drinking and medicinal herbs component be Chinese cassia tree, it is pueraria lobata, Rhizoma Atractylodis Macrocephalae, Poria cocos, malt, radix glycyrrhizae, corydalis tuber, rhizoma zingiberis, anti-
At least one of wind, banksia rose;More preferably Chinese cassia tree, pueraria lobata, Poria cocos, malt, radix glycyrrhizae.
Preferably, the natural plants compound is l-cn, Glucosamine, oligofructose, lutein, plant steroid
At least one of alcohol, lycopene, resveratrol, allicin;More preferably l-cn.
Preferably, the new resource food is γ-aminobutyric acid, chitosan oligosaccharide, eucommia Bark male flower, bamboo-leaves flavones, casein phosphorus
Sour peptide, avenabeta glucosan, Oligomeric manna sugar, arachidonic acid oil, stachyose, Rosa roxburghii Tratt, yeast beta-dextran, xylo-oligosaccharide
At least one of;More preferably chitosan oligosaccharide, yeast beta-dextran.
Active probiotic is further included in above-mentioned nutrient formulation;Active probiotic stimulates intestines to maintaining intestinal flora balance
Road moves, and improves defecation, suppresses harmful bacteria propagation, reduces harmful substance generation, and treatment function of intestinal canal disorder has better effects, fits
The crowd for closing lactose intolerance drinks, and peomotes the absorption of the nutriment such as protein, monose and calcium, magnesium, produces dimension life
A large amount of benefit materials such as plain B races, immunoregulation effect, strengthens body immunity and resistance.
Micro qi-regulating Chinese medicine is further included in above-mentioned nutrient formulation;Qi-regulating Chinese medicine, which can effectively alleviate lactose intolerance, to be caused
Symptom of diarrhea, strengthening the spleen and replenishing qi, stomach spleen nourishing the stomach, nurses one's health enteron aisle, and has no toxic side effect.
Preferably, the qi-regulating Chinese medicine for Chinese cassia tree, pueraria lobata, Rhizoma Atractylodis Macrocephalae, Poria cocos, malt, radix glycyrrhizae, corydalis tuber, rhizoma zingiberis, it is windproof,
At least one of banksia rose.
Second object of the present invention is to provide a kind of by above-mentioned children's lactose intolerance tailored version clinical nutrition formula system
The standby method into nutrient powder, it includes the following steps:
Step 1, fat powder, liposoluble vitamin powder and water soluble vitamin powder are prepared using micro-capsule embedding techniques
End, sterilization are spare;
Step 2, carried, be spray-dried and sifting step prepares integration of drinking and medicinal herbs component powders, sterilization using crushing, alcohol extracting, water
It is spare;
Step 3, by the protein of predetermined weight, carbohydrate, dietary fiber, macroelement, trace element, meals essence
China, natural plants compound and new resource food are prepared into the powder that particle diameter is 150~300 μm respectively, and sterilization is spare;
Step 4, it is powder made from step 1~3 is canned in packaging bag or in pail pack after mixing;
Wherein, the order of step 1~3 can be replaced mutually.
The present invention also provides the side that a kind of above-mentioned children's lactose intolerance tailored version clinical nutrition formula is prepared into nutritional agents
Method, it is wet processing, is included the following steps:
Step 1, fat powder, liposoluble vitamin powder and water soluble vitamin powder are prepared using micro-capsule embedding techniques
End, sterilization are spare;
Step 2, carried, be spray-dried and sifting step prepares integration of drinking and medicinal herbs component powders, sterilization using crushing, alcohol extracting, water
It is spare;
Step 3, by the protein of predetermined weight, carbohydrate, dietary fiber, macroelement, trace element, meals essence
China, natural plants compound and new resource food are prepared into the powder that particle diameter is 100~200 μm respectively, and sterilization is spare;
Step 4, powder made from step 1-3 is dissolved separately in a certain amount of water and aqueous solution is made;
Step 5, stirred after the aqueous solution that step 4 obtains is mixed at 55-65 DEG C, adjust ph to 6.5-6.8, mixed
Close solution;
Step 6, under the protection of nitrogen, by mixed solution under 20-40MPa pressure homogeneous, after kept at 70-80 DEG C
20-30 seconds, postcooling was to 2-6 DEG C;
Wherein, the order of step 1~3 can be replaced mutually.
In above two preparation method, it is preferable that the specific implementation step of the fatty micro-capsule embedding techniques is as follows:
A) wall material aqueous solution is prepared:Take maltodextrin, hydrolyzed milk protein powder, dietary fiber, inulin, PURE WHEY (lactose-free),
Oligoisomaltose, 1 gram of soybean fiber, Arabic gum, candy sugar powder and water stir evenly;B) monoglyceride is dissolved in grease;
C) Tween 80 is dissolved in wall material aqueous solution;D) liquid of blend step b) and step c), obtains mixed solution;E) addition is steady
Agent agar is determined in mixed solution, constant volume, high speed dispersion under 20000r/min;F) under conditions of homogenization pressure is 25MPa,
Matter 3 times, is made homogeneous emulsion;G) obtained homogeneous emulsion is spray-dried, inlet air temperature is 195 DEG C, goes out wind-warm syndrome
Spend for 80 DEG C;Collect and fat powder is made.
Preferably, the specific implementation step of the micro-capsule embedding techniques of the liposoluble vitamin is as follows:By predetermined weight part
Several liposoluble vitamins selects carragheen, Arabic gum to carry out 2 emulsifying homogeneous under high pressure as wall material as core
Processing, the emulsifying homogeneous time is 10~15min, then carries out instantaneous drying of spraying, and fat-soluble dimension is prepared with 60~80 mesh sieves point
Raw element powder.
Preferably, the specific implementation step of the micro-capsule embedding techniques of the water soluble vitamin is as follows:By predetermined weight part
Several water soluble vitamins is selected maltodextrin, lipoprotein to be used as wall material, is uniformly mixed as core, the instantaneous drying of spraying, with
60~80 mesh sieves point prepare water soluble vitamin powder.
Preferably, the preparation process of the integration of drinking and medicinal herbs component powders is as follows:Using pulverizer to predetermined weight number
Raw material is crushed, and the raw material of crushing is placed in container, is added 3~8 times of the water that weight is raw material weight, is carried out immersion 3
~4 it is small when, then carry out 30~60min of decoction to soak, filtering removes raw material, leaves and takes decoction liquor, decoction liquor is sprayed
Mist is dried, and integration of drinking and medicinal herbs component powders are prepared with 60~80 mesh sieves point.
In the present invention using include peameal, mung bean flour, black bean powder, red bean powder, soy meal, spinach powder, broccoli powder,
Apple powder, salmon powder, the meals elite of orange powder, without milk component, will not cause lactose intolerance symptom, and with abundant
Nutrition, strengthen calcium uptake, supplement children lack due to a lack of calcium source caused by dairy products.
Using the new resource food for including chitosan oligosaccharide and yeast beta-dextran in the present invention, have after mentioned component compatibility synergy
Have and promote intestinal beneficial flora growth, conditioning function of intestinal canal, the function of improving body immunity, promote nutrient absorption, especially
Suitable for children lactose-intolerant person.
Chitosan oligosaccharide is that through special biological enzyme technology (chitosan is also had the report using chemical degradation, microwave degradation technology
Road) obtained a kind of degree of polymerization of degrading oligosaccharide product, molecular weight≤3200Da between 2~20 are that water-soluble preferable, function is made
With the high low molecular weight product of big, bioactivity, there is the unexistent higher solubility of chitosan, be dissolved in water entirely, easily given birth to
Object such as absorbs at many unique functions, while the microbiota metabolic activity in adjustable animal intestinal tract, selectively activation,
Breed beneficial bacterium growth, promote the human body profitable strain such as the absorption of calcium and mineral matter, propagation Bifidobacterium, lactic acid bacteria, improve machine
Body immunocompetence;Adjusted suitable for the function of intestinal canal of children, promote the increment of active flora, to conditioning lactose-intolerant person's
Symptom has to be acted on well.
Yeast beta-dextran is obtained by extraction from bread leaven matricyte wall, has the Tiny ecosystem of adjusting body digested road,
Promote the propagation of internal beneficial bacterium, recover the stomach absorption function of baby as early as possible, while enhancing NK cells, macrophage can be stimulated thin
The phagocytic activity of the immunocytes such as born of the same parents, stimulates release interleukin to strengthen body immunity.
The present invention uses above-mentioned technical proposal, compared with prior art, has the following technical effect that:
Children's lactose intolerance tailored version clinical nutrition formula of the present invention includes lactalbumin (lactose-free), hydrolysed milk
8 kinds supplemented needed for children must the protein general equilibriums such as albumen, soybean protein isolate, hydrolysis Isin glue collagen, taurine
Amino acid is needed, without lactose constituent, the albumen demand of particular time children, low fat ratio, Hi CHO ratio can be supplemented
Example, can prevent that fat intake is excessive and produces laxation, not only improve nutrition needed for supplement children, and easily inhaled for children intestinal digestion
Receive;
Strengthen taurine, using the teaching of the invention it is possible to provide human body oxidation resistance, strengthens immunity of organisms;
Strengthen calcium, calcium is the main component for forming children's bone and tooth, can promote upgrowth and development of children, and it is close to improve bone
Degree;
Strengthen iron, zinc, iron is the important element for forming hemoglobin, can prevent children anemia;Zinc is needed by human
One of trace element, is the constituent of a variety of enzymes, it widely participates in various metabolic activities, is conducive to skin, bone and tooth
The normal growth of tooth, promotes children's appetite, helps to strengthen children physique, so as to strengthen the body immunity of children;
A variety of fat-soluble type vitamin rational proportions, vitamin D can promote the absorption of calcium phosphorus, maintain calcium, phosphorus in blood
Level, promotes the growth of children's bone and tooth;
Strengthen l-cn, l-cn category conditionity baby's required nutriment, energy is used as in baby by the use of fat
Play an important role in the metabolism in source, it not only plays an important role in energy production and fat metabolic process, but also is tieing up
Hold baby's life and promote infant development some physiology courses, as the ketogenesis, nitrogen metabolism etc. be respectively provided with it is certain
Function, helps to strengthen the body immunity of children;
Yeast beta-dextran can effective adjusting body digested road Tiny ecosystem, promote the propagation of internal beneficial bacterium, it is extensive as early as possible
The stomach absorption function of multiple baby, while the phagocytic activity of the immunocytes such as enhancing NK cells, macrophage can be stimulated, stimulate
Interleukin is discharged to strengthen body immunity;
For active probiotic to maintaining intestinal flora balance, stimulation intestinal movement, improves defecation, suppresses harmful bacteria propagation,
Harmful substance generation is reduced, treatment function of intestinal canal disorder there are better effects, is adapted to the crowd of lactose intolerance to drink, helps to promote
Into the absorption of the nutriment such as protein, monose and calcium, magnesium, a large amount of benefit materials such as vitamin B complex are produced, immunological regulation is made
With enhancing body immunity and resistance.
The present invention is by selecting rational basal nutrient element, using the proportioning of general equilibrium, while adds to have and promotes intestines
The growth of road profitable strain, conditioning function of intestinal canal, improve body immunity, promote nutrient absorption function meals elite, new
The specific nutrients such as resource food, natural plants compound, and adjust its proportioning and carry out compatibility synergy with basal nutrient element, comprehensively
The necessary nutritional ingredient needed for children lactose-intolerant person is supplemented, and the nutrient formulation is free of lactose, easily by children's lactose not
Intolerant patient digests and assimilates, the effect of giving full play to its each component, so as to making children put on weight as early as possible in convalescence and
Improve human body nutrition condition comprehensively.
Embodiment
The present invention provides a kind of children's lactose intolerance tailored version clinical nutrition formula, including following component and its weight
Number:15-22 parts of protein, 6-10 parts of fat, 43-58 parts of carbohydrate, 7-10 parts of dietary fibers, 0.7-1.1 parts of constants
Element, 0.004-0.01 parts of trace elements, 0.001-0.003 parts of liposoluble vitamins, 0.01-0.03 parts of water soluble vitamins,
0.005-0.1 parts of meals elite, 0.0005-0.5 parts of integration of drinking and medicinal herbs components, 0.05-0.4 parts of natural plants compounds and
0.01-0.02 parts of new resource foods.
With reference to embodiment, the embodiment of the present invention is further described.Following embodiments are only used for more
Add and clearly demonstrate technical scheme, and be not intended to limit the protection scope of the present invention and limit the scope of the invention.
Embodiment 1
Children's lactose intolerance tailored version clinical nutrition formula of the present invention include lactalbumin (lactose-free) 2.8g,
Hydrolyzed milk protein 1.68g, soybean protein isolate 0.63g, hydrolysis Isin glue collagen 0.33g, taurine 0.02g;DHA0.02g、
Walnut oil 2.1g, olive oil 1.1g, peanut oil 3.1g;Maltodextrin 7.23g, rock sugar 1.1g;Konjaku flour 1.1g, polyfructosan
1.1g;Calcium 0.4g, phosphorus 0.229g, potassium 0.1g, sodium 0.145g, magnesium 0.147g in macroelement;Iron 0.005g, zinc in trace element
0.004g;Beta carotene 0.0008g, vitamin K10.0005g, vitamin D30.0002g, vitamin E 0.0017g;Vitamin
B20.0013g, vitamin B60.0013g, vitamin C 0.01g, folic acid 0.0002g, nicotinic acid 0.0002g, biotin 0.0002g;
Peameal 0.01g, mung bean flour 0.01g, black bean powder 0.01g, red bean powder 0.01g, soy meal 0.01g, spinach powder 0.01g, west are blue
Pollen 0.01g, salmon powder 0.01g, apple powder 0.01g, orange powder 0.01g;Chinese cassia tree 0.03g, pueraria lobata 0.03g, Poria cocos
0.03g, malt 0.03g, radix glycyrrhizae 0.03g;L-cn 0.1g;Chitosan oligosaccharide 0.1g, yeast beta-dextran 0.1g;Active probiotic
0.1g。
Embodiment 2
Children's lactose intolerance tailored version clinical nutrition formula of the present invention include lactalbumin (lactose-free) 2.8g,
Hydrolyzed milk protein 1.68g, soybean protein isolate 0.63g, hydrolysis Isin glue collagen 0.33g, taurine 0.02g;DHA0.02g、
Walnut oil 2.1g, olive oil 1.1g, peanut oil 3.1g;Maltodextrin 7.23g, rock sugar 1.1g;Konjaku flour 1.1g, polyfructosan
1.1g;Calcium 0.4g, phosphorus 0.229g, potassium 0.1g, sodium 0.145g, magnesium 0.147g in macroelement;Iron 0.005g, zinc in trace element
0.004g;Beta carotene 0.0008g, vitamin K1 0.0005g, vitamine D3 0.0002g, vitamin E 0.0017g;Dimension life
Plain B20.0013g, vitamin B6 0.0013g, vitamin C 0.01g, folic acid 0.0002g, nicotinic acid 0.0002g, biotin
0.0002g;Peameal 0.01g, mung bean flour 0.01g, black bean powder 0.01g, red bean powder 0.01g, soy meal 0.01g, spinach powder
0.01g, broccoli powder 0.01g, salmon powder 0.01g, apple powder 0.01g, orange powder 0.01g;Chinese cassia tree 0.01g, pueraria lobata
0.01g, Poria cocos 0.01g, malt 0.01g, radix glycyrrhizae 0.01g;L-cn 0.1g;Chitosan oligosaccharide 0.1g, yeast beta-dextran 0.1g;
Active probiotic 0.1g.
Embodiment 3
Children's lactose intolerance tailored version clinical nutrition formula of the present invention include lactalbumin (lactose-free) 0.8g,
Hydrolyzed milk protein 0.08g, soybean protein isolate 3.23g, hydrolysis Isin glue collagen 0.33g, taurine 0.02g;DHA0.02g、
Walnut oil 2.1g, olive oil 1.1g, peanut oil 3.1g;Maltodextrin 7.23g, rock sugar 1.1g;Konjaku flour 1.1g, polyfructosan
1.1g;Calcium 0.4g, phosphorus 0.229g, potassium 0.1g, sodium 0.145g, magnesium 0.147g in macroelement;Iron 0.005g, zinc in trace element
0.004g;Beta carotene 0.0008g, vitamin K1 0.0005g, vitamine D3 0.0002g, vitamin E 0.0017g;Dimension life
Plain B20.0013g, vitamin B6 0.0013g, vitamin C 0.01g, folic acid 0.0002g, nicotinic acid 0.0002g, biotin
0.0002g;Peameal 0.01g, mung bean flour 0.01g, black bean powder 0.01g, red bean powder 0.01g, soy meal 0.01g, spinach powder
0.01g, broccoli powder 0.01g, salmon powder 0.01g, apple powder 0.01g, orange powder 0.01g;Chinese cassia tree 0.01g, pueraria lobata
0.01g, Poria cocos 0.01g, malt 0.01g, radix glycyrrhizae 0.01g;L-cn 0.1g;Chitosan oligosaccharide 0.1g, yeast beta-dextran 0.1g;
Active probiotic 0.1g.
Embodiment 4
The present embodiment verifies influence of the nutrient formulation of the present invention to children lactose-intolerant person.The present embodiment is adopted
The pulvis prepared with the formula of embodiment 2 and following comparative examples:
Comparative example 1:Western medicine selects the medicines such as antibiotic, antidiarrheic, probiotics, while continues newborn class diet and feed
Support.
Comparative example 2:Soybean protein isolate substitutes animal protein entirely, the pulvis that remaining component is prepared by the formula of embodiment 2;
Comparative example 3:Integration of drinking and medicinal herbs component is not added, the pulvis that remaining component is prepared by the formula of embodiment 2;
4 groups of experimental group of setting, every group of selection lactose intolerance children 30, by each 1g/kg of weight, daily 2-4 clothes
With.All cases do not limit infusion.Acute person continuously observes 5 days, and chronic, unresolved continuous observation 10 days, records daily abdomen
Rush down, generate heat, vomitting, the change situation of the symptom such as abdominal distension.Each group children carry out routine care.Therapy lasted is bright to each group symptom
Untill aobvious improvement.Experimental result is as shown in table 1:
1 each group symptom average cure time of table compare (my god,)
Compared with 1 group of comparative example, * P < 0.05;It is number of cases in bracket
As seen from the above table, 2 nutrient formulation of embodiment cannot shorten the healing time of children with acute diarrhea in the present invention, still
The symptoms such as diarrhea, abdominal distension, vomiting can be alleviated rapidly;Comparative example 2 can shorten chronic, persisting diarrhea healing time, rapidly
Alleviate the symptoms such as diarrhea, vomiting, abdominal distension.Comparative example 1-3 also has certain effect, but its effect be somewhat weaker than it is of the present invention
Nutrient formulation.
By above-described embodiment, a kind of children's lactose intolerance tailored version clinical nutrition formula of the present invention and
Its preparation method, its clinical nutrition feature not tolerated according to children, rightly matches somebody with somebody protein, carbohydrate and fat mass
Than being adjusted, strengthen calcium uptake, while alleviate the symptom of diarrhea of children lactose-intolerant person, nurse one's health enteron aisle, promote enteron aisle
Digest and assimilate, strengthen children's immunity of organisms.
The specific embodiment of the present invention is described in detail above, but it is intended only as example, it is of the invention and unlimited
It is formed on particular embodiments described above.To those skilled in the art, it is any to the equivalent modifications that carry out of the present invention and
Substitute also all among scope of the invention.Therefore, the impartial conversion made without departing from the spirit and scope of the invention and
Modification, all should be contained within the scope of the invention.
Claims (10)
1. a kind of children's lactose intolerance tailored version clinical nutrition formula, it is characterised in that including following component and its parts by weight
Number:15-22 parts of protein, 6-10 parts of fat, 43-58 parts of carbohydrate, 7-10 parts of dietary fibers, 0.7-1.1 parts of constant members
Element, 0.004-0.01 parts of trace elements, 0.001-0.003 parts of liposoluble vitamins, 0.01-0.03 parts of water soluble vitamins,
0.005-0.1 parts of meals elite, 0.0005-0.5 parts of integration of drinking and medicinal herbs components, 0.05-0.4 parts of natural plants compounds and
0.01-0.02 parts of new resource foods;
Wherein, the protein is lactalbumin (lactose-free), hydrolyzed milk protein, soybean protein isolate, hydrolysis collagen egg
In vain, at least one of amino acid, protein peptides;
Wherein, it is fine to include inulin, konjaku flour, polyfructosan, soybean polyoses, cyclodextrin, resistant dextrin, soybean for the dietary fiber
At least one of dimension.
2. a kind of children's lactose intolerance tailored version clinical nutrition formula according to claim 1, it is characterised in that described
Protein includes lactalbumin (lactose-free), hydrolyzed milk protein, soybean protein isolate, hydrolysis Isin glue collagen, taurine.
3. a kind of children's lactose intolerance tailored version clinical nutrition formula according to claim 1, it is characterised in that described
Carbohydrate includes at least two in fructose, rock sugar, maltodextrin, rock sugar, tapioca, resistant starch.
4. a kind of children's lactose intolerance tailored version clinical nutrition formula according to claim 1, it is characterised in that described
Dietary fiber is konjaku flour and polyfructosan.
5. a kind of children's lactose intolerance tailored version clinical nutrition formula according to claim 1, it is characterised in that described
Integration of drinking and medicinal herbs component is at least one in Chinese cassia tree, pueraria lobata, Rhizoma Atractylodis Macrocephalae, Poria cocos, malt, radix glycyrrhizae, corydalis tuber, rhizoma zingiberis, the windproof, banksia rose
Kind.
6. a kind of children's lactose intolerance tailored version clinical nutrition formula according to claim 1, it is characterised in that described
Natural plants compound is l-cn, Glucosamine, oligofructose, lutein, phytosterol, lycopene, white black false hellebore
At least one of alcohol, allicin.
7. a kind of children's lactose intolerance tailored version clinical nutrition formula according to claim 1, it is characterised in that described
New resource food is γ-aminobutyric acid, chitosan oligosaccharide, eucommia Bark male flower, bamboo-leaves flavones, casein phosphopeptide, avenabeta glucosan, low
At least one of poly- mannose, arachidonic acid oil, stachyose, Rosa roxburghii Tratt, yeast beta-dextran, xylo-oligosaccharide.
8. a kind of children's lactose intolerance tailored version clinical nutrition formula according to claim 1, it is characterised in that described
Nutrient formulation further includes active probiotic.
9. nutrition is prepared according to children's lactose intolerance tailored version clinical nutrition formula according to any one of claims 1 to 8
The method of powder, it is characterised in that it includes the following steps:
Step 1, fat powder, liposoluble vitamin powder and water soluble vitamin powder are prepared using micro-capsule embedding techniques, killed
Bacterium is spare;
Step 2, carried, be spray-dried and sifting step prepares integration of drinking and medicinal herbs component powders using crushing, alcohol extracting, water, sterilization is spare;
Step 3, by the protein of predetermined weight, carbohydrate, dietary fiber, macroelement, trace element, meals elite,
Natural plants compound and new resource food are prepared into the powder that particle diameter is 150~300 μm respectively, and sterilization is spare;
Step 4, it is powder made from step 1~3 is canned in packaging bag or in pail pack after mixing;
Wherein, the order of step 1~3 can be replaced mutually.
10. nutrition is prepared according to children's lactose intolerance tailored version clinical nutrition formula according to any one of claims 1 to 8
The method of agent, it is wet processing, it is characterised in that is included the following steps:
Step 1, fat powder, liposoluble vitamin powder and water soluble vitamin powder are prepared using micro-capsule embedding techniques, killed
Bacterium is spare;
Step 2, carried, be spray-dried and sifting step prepares integration of drinking and medicinal herbs component powders using crushing, alcohol extracting, water, sterilization is spare;
Step 3, by the protein of predetermined weight, carbohydrate, dietary fiber, macroelement, trace element, meals elite,
Natural plants compound and new resource food are prepared into the powder that particle diameter is 100~200 μm respectively, and sterilization is spare;
Step 4, powder made from step 1-3 is dissolved separately in a certain amount of water and aqueous solution is made;
Step 5, stirred after the aqueous solution that step 4 obtains is mixed at 55-65 DEG C, adjust ph to 6.5-6.8, it is molten to obtain mixing
Liquid;
Step 6, under the protection of nitrogen, by mixed solution under 20-40MPa pressure homogeneous, after keep 20- at 70-80 DEG C
30 seconds, postcooling was to 2-6 DEG C;
Wherein, the order of step 1~3 can be replaced mutually.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201711332713.8A CN108013453A (en) | 2017-12-13 | 2017-12-13 | Children's lactose intolerance tailored version clinical nutrition formula and preparation method thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201711332713.8A CN108013453A (en) | 2017-12-13 | 2017-12-13 | Children's lactose intolerance tailored version clinical nutrition formula and preparation method thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
CN108013453A true CN108013453A (en) | 2018-05-11 |
Family
ID=62073517
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201711332713.8A Pending CN108013453A (en) | 2017-12-13 | 2017-12-13 | Children's lactose intolerance tailored version clinical nutrition formula and preparation method thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN108013453A (en) |
Cited By (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109497520A (en) * | 2018-11-15 | 2019-03-22 | 上海奥医生物医药科技有限公司 | A kind of self-closing disease tailored version clinical nutrition composition and preparation method thereof |
CN109497554A (en) * | 2018-11-15 | 2019-03-22 | 上海奥医生物医药科技有限公司 | A kind of promotion lactation tailored version clinical nutrition composition and preparation method thereof |
CN109527541A (en) * | 2018-11-15 | 2019-03-29 | 上海奥医生物医药科技有限公司 | A kind of gastrointestinal absorption obstacle tailored version clinical nutrition composition and preparation method thereof |
CN109527379A (en) * | 2019-01-05 | 2019-03-29 | 江西巨日食品有限公司 | A kind of nourishing rice flour for babies and preparation method thereof for nursing enteron aisle |
CN109673986A (en) * | 2019-01-28 | 2019-04-26 | 广州佳明食品科技有限公司 | A kind of pueraria lobata composite powder and preparation method thereof |
CN110140969A (en) * | 2019-06-26 | 2019-08-20 | 北京诺康达医药科技股份有限公司 | A kind of preparation process thereof containing powder and the full nutrient formulation powder of tumour using its preparation |
CN110432482A (en) * | 2019-07-05 | 2019-11-12 | 上海奥医高科技实业有限公司 | A kind of infant allergic dermatitis tailored version clinical nutrition formula and preparation method thereof |
CN114007436A (en) * | 2019-06-13 | 2022-02-01 | N·V·努特里奇亚 | Process for preparing substantially lactose-free infant formula |
EP3834626A4 (en) * | 2018-08-10 | 2022-05-11 | Cao, Jingjing | Composition for treating diarrhea |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106579460A (en) * | 2016-12-23 | 2017-04-26 | 上海奥医生物医药科技有限公司 | Special clinical nutrition formula for fracture and preparation method thereof |
CN106858620A (en) * | 2017-03-29 | 2017-06-20 | 上海奥医生物医药科技有限公司 | A kind of anaemia tailored version clinical nutrition formula and preparation method thereof |
CN106962912A (en) * | 2017-03-29 | 2017-07-21 | 上海奥医生物医药科技有限公司 | A kind of hepatopathy tailored version clinical nutrition formula and preparation method thereof |
CN106983136A (en) * | 2017-03-29 | 2017-07-28 | 上海奥医生物医药科技有限公司 | A kind of puerperium conditioning tailored version clinical nutrition formula and preparation method thereof |
CN106983151A (en) * | 2017-03-29 | 2017-07-28 | 上海奥医生物医药科技有限公司 | A kind of inflammatory bowel disease tailored version clinical nutrition formula and preparation method thereof |
CN107440120A (en) * | 2017-08-23 | 2017-12-08 | 上海奥医生物医药科技有限公司 | A kind of children's monophagia and anorexia tailored version clinical nutrition formula particular about food and preparation method thereof |
-
2017
- 2017-12-13 CN CN201711332713.8A patent/CN108013453A/en active Pending
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106579460A (en) * | 2016-12-23 | 2017-04-26 | 上海奥医生物医药科技有限公司 | Special clinical nutrition formula for fracture and preparation method thereof |
CN106858620A (en) * | 2017-03-29 | 2017-06-20 | 上海奥医生物医药科技有限公司 | A kind of anaemia tailored version clinical nutrition formula and preparation method thereof |
CN106962912A (en) * | 2017-03-29 | 2017-07-21 | 上海奥医生物医药科技有限公司 | A kind of hepatopathy tailored version clinical nutrition formula and preparation method thereof |
CN106983136A (en) * | 2017-03-29 | 2017-07-28 | 上海奥医生物医药科技有限公司 | A kind of puerperium conditioning tailored version clinical nutrition formula and preparation method thereof |
CN106983151A (en) * | 2017-03-29 | 2017-07-28 | 上海奥医生物医药科技有限公司 | A kind of inflammatory bowel disease tailored version clinical nutrition formula and preparation method thereof |
CN107440120A (en) * | 2017-08-23 | 2017-12-08 | 上海奥医生物医药科技有限公司 | A kind of children's monophagia and anorexia tailored version clinical nutrition formula particular about food and preparation method thereof |
Cited By (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP3834626A4 (en) * | 2018-08-10 | 2022-05-11 | Cao, Jingjing | Composition for treating diarrhea |
US11819529B2 (en) | 2018-08-10 | 2023-11-21 | Tianjin Geonatural Technology Co., Ltd. (CN) | Composition for treating diarrhea |
CN109497520A (en) * | 2018-11-15 | 2019-03-22 | 上海奥医生物医药科技有限公司 | A kind of self-closing disease tailored version clinical nutrition composition and preparation method thereof |
CN109497554A (en) * | 2018-11-15 | 2019-03-22 | 上海奥医生物医药科技有限公司 | A kind of promotion lactation tailored version clinical nutrition composition and preparation method thereof |
CN109527541A (en) * | 2018-11-15 | 2019-03-29 | 上海奥医生物医药科技有限公司 | A kind of gastrointestinal absorption obstacle tailored version clinical nutrition composition and preparation method thereof |
CN109527379A (en) * | 2019-01-05 | 2019-03-29 | 江西巨日食品有限公司 | A kind of nourishing rice flour for babies and preparation method thereof for nursing enteron aisle |
CN109673986A (en) * | 2019-01-28 | 2019-04-26 | 广州佳明食品科技有限公司 | A kind of pueraria lobata composite powder and preparation method thereof |
CN114007436A (en) * | 2019-06-13 | 2022-02-01 | N·V·努特里奇亚 | Process for preparing substantially lactose-free infant formula |
CN110140969A (en) * | 2019-06-26 | 2019-08-20 | 北京诺康达医药科技股份有限公司 | A kind of preparation process thereof containing powder and the full nutrient formulation powder of tumour using its preparation |
CN110432482A (en) * | 2019-07-05 | 2019-11-12 | 上海奥医高科技实业有限公司 | A kind of infant allergic dermatitis tailored version clinical nutrition formula and preparation method thereof |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN108013453A (en) | Children's lactose intolerance tailored version clinical nutrition formula and preparation method thereof | |
CN106579393A (en) | Special clinical nutrient formula for diabetes and preparation method thereof | |
CN104544432B (en) | Samara oil compound protein solid beverage and method for preparing same | |
CN106858620A (en) | A kind of anaemia tailored version clinical nutrition formula and preparation method thereof | |
CN106666728A (en) | Special clinical nutrient composition for gestational diabetes and preparation method of nutrient composition | |
CN107319525A (en) | One kind fat-reducing fat reducing tailored version clinical nutrition formula and preparation method thereof | |
CN108812909B (en) | Complementary food nutritional supplement for improving monophagia or anorexia and preparation method thereof | |
CN108651988A (en) | Nephrosis dialysis tailored version clinical nutrition formula and preparation method thereof | |
CN107927754A (en) | Tailored version clinical nutrition formula and preparation method thereof is energized during one kind production | |
CN108013452A (en) | A kind of puerperal abdominal flatulence gas tailored version clinical nutrition formula and preparation method thereof | |
CN108077911A (en) | A kind of epileptic's tailored version clinical nutrition formula and preparation method thereof | |
CN107616490A (en) | A kind of postoperative tailored version clinical nutrition formula of children and preparation method thereof | |
CN107440120A (en) | A kind of children's monophagia and anorexia tailored version clinical nutrition formula particular about food and preparation method thereof | |
CN110074397A (en) | A kind of upgrowth and development of children tailored version clinical nutrition formula and preparation method thereof | |
CN110037127A (en) | A kind of probiotics preparation and preparation method thereof improving infant's enteron aisle | |
CN110301629A (en) | A kind of full nutrient solid beverage of tumor patient and preparation method thereof | |
CN109169916A (en) | A kind of puerpera's nutriment and its production technology | |
CN107440121A (en) | A kind of Single Obesity tailored version clinical nutrition formula and preparation method thereof | |
CN108703365A (en) | Protein allergy tailored version clinical nutrition formula and preparation method thereof | |
CN106720456A (en) | Solid beverage composition containing WPC and preparation method thereof | |
CN107440102A (en) | A kind of climacteric women tailored version clinical nutrition formula and preparation method thereof | |
CN110214941A (en) | A kind of full nutrition special medicine purposes formula nutritional powder of adult and preparation method thereof | |
CN107594109A (en) | A kind of pet drinks enzyme liquid and preparation method thereof | |
CN109156535A (en) | A kind of maternal nutritional product and its production technology | |
CN106418501A (en) | Healthcare food with weight reducing function |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20180511 |
|
RJ01 | Rejection of invention patent application after publication |